For the best experienceDownload the Mobile App
App Store Play Store
Central Oregon patients gain access to newly approved breakthrough cancer medication
Central Oregon patients gain access to newly approved breakthrough cancer medication
Central Oregon patients gain access to newly approved breakthrough cancer medication

Published on: 08/26/2026

This news was posted by Oregon Today News

Go To Business Place

Description

john-johnson.00_00_00_00.Still001.jpg
CENTRAL OREGON (KTVZ) -- The Food and Drug Administration approved daraxonrasib Aug. 26, offering a new treatment option for patients with stage 4 metastatic pancreatic cancer. Early research shows the medication doubles average life expectancy for patients with advanced stages of the disease from six to 13 months. Seven patients at St. Charles Cancer Institute

News Source : https://ktvz.com/health/2026/08/26/central-oregon-patients-gain-access-to-newly-approved-breakthrough-cancer-medication/

Other Related News

Trump says the US doesn’t need Canada. The economy says otherwise
Trump says the US doesn’t need Canada. The economy says otherwise

08/26/2026

Trump claims Canada needs the US but Canada supplies oil and aluminum for starters

A judge suspends charges against an ex-Marine arrested on Trump's golf course with ammunition
A judge suspends charges against an ex-Marine arrested on Trump's golf course with ammunition

08/26/2026

A former US Marine arrested at President Donald Trumps Los Angeles-area golf course had hi...

Central Oregon water supplies strained as drought grips region
Central Oregon water supplies strained as drought grips region

08/26/2026

Persistent drought is reducing streamflow and reservoirs across Central Oregon threatening...

Women’s Equality Day highlights Portland’s women-owned businesses
Women’s Equality Day highlights Portland’s women-owned businesses

08/26/2026

Womens Equality Day on Aug 26 spotlights the 19th Amendment and women-owned businesses pow...

ShoutoutGive Shoutout
500/500